Microbial Contamination Test of Ceftriaxone Infusion Solutions
Main Article Content
Abstract
Ceftriaxone is an antibiotic belonging to the third generation of cephalosporins. It is commonly prescribed to treat various infectious diseases in hospitalized patients. While ceftriaxone infusion solution is chemically stable for 2–10 days, the expiration date is limited to approximately 24 hours due to a lack of data on microbiological stability beyond this period. Therefore, this study aimed to investigate the microbial contamination of ceftriaxone infusion solutions stored beyond 24 hours to establish an appropriate expiration date. Methods: Ceftriaxone infusion solution was prepared under a laminar airflow environment to achieve final concentrations of 10–20 mg/mL. There were four groups of ceftriaxone solutions. Group 1 comprised 20 samples of a 10 mg/mL ceftriaxone solution stored at room temperature (28–30 ºC). Groups 2 and 3 included 20 samples each of 20 mg/mL ceftriaxone stored at room temperature (28–30 ºC) and under refrigeration (2–8 °C), respectively. Group 4 consisted of 15 samples of 48-hour-old leftover ceftriaxone solutions stored in a refrigerator (2–8 ºC) at hospital wards. Microbial contamination was determined using the direct inoculation method; fluid thioglycolate media was incubated at 30–35 ºC for the detection of aerobic and anaerobic bacteria, while soybean-casein digest media was incubated at 20–25 ºC for the detection of fungi, and both were observed for a period of 14 days. Results: After a 10-day period of preparation and storage, all ceftriaxone test samples in groups 1, 2, and 3 were negative for microbial growth. Similarly, the leftover ceftriaxone solutions in Group 4 exhibited no bacterial contamination. Conclusion: Ceftriaxone infusion solutions 10–20 mg/mL demonstrated biological stability for at least ten days post-preparation. However, considering the limitations of chemical stability, the recommended expiration dates for ceftriaxone solutions are 30 hours when stored at 28-30 ºC, 48 hours when stored at 25 ºC, and up to 10 days when stored at 2-8 ºC.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
In the case that some parts are used by others The author must Confirm that obtaining permission to use some of the original authors. And must attach evidence That the permission has been included
References
American Society of Health-System Pharmacists. ASHP guidelines on compounding sterile preparations. Am J Health Syst Pharm. 2014;71(2):145-66.
Austin PD, Hand KS, Elia M. Systematic review and meta-analysis of the risk of microbial contamination of parenteral doses prepared under aseptic techniques in clinical and pharmaceutical environments: an update. J Hosp Infect. 2015;91(4):306-18.
Bureau of Drug and Narcotic, Department of Medical Sciences, Ministry of Public Health. Microbiological tests: Sterility test. 2011. In: Thai Pharmacopeia II [Internet]. [Cited 2024 March 22]. Available from: https://www.bdn.go.th/tp/ebook/qQqcA3t0pR9gC3q0GT5gMJq0qT5co3uw.
Bureau of Drug and Narcotic, Department of Medical Sciences, Ministry of Public Health. Microbiological tests: Microbial limit tests. 2011. In: Thai Pharmacopeia II [Internet]. [Cited 2024 March 22]. Available from: https://www.bdn.go.th/tp/ebook/qQMcA3t0pR9gC3q0GT5gMJq0qT5co3uw.
Ceftriaxone for injection [package insert]. U.S. Food and Drug Administration. Revised July 2018 [Cited Feb 2024]. Available from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050585.
Clinical and Laboratory Standard Institute (CLSI). Performance standard for antimicrobial susceptibility testing. 34th ed. Wayne, PA: Clinical and laboratory standard institute; 2024.
Esteban MJ, Cantón E, Rius F. Influence of temperature on degradation kinetics of ceftriaxone in diluted and undiluted human serum. Antimicrob Agents Chemother. 1990;34(6):1268-70.
European Committee on Antimicrobial Susceptiblity Testing (EUCAST). MIC and zone diameter distributions and ECOFFs [Internet]. 2024 [Cited 18 March 2024]. Available from: https://mic.eucast.org/.
Herrera-Hidalgo L, López-Cortes LE, Luque-Márquez R, Gálvez-Acebal J, de Alarcón A, López-Cortes LF, et al. Ampicillin and ceftriaxone solution stability at different temperatures in outpatient parenteral antimicrobial therapy. Antimicrob Agents Chemother. 2020;64(7):e00309-20.
Larmené-Beld KHM, Frijlink HW, Taxis K. A systematic review and meta-analysis of microbial contamination of parenteral medication prepared in a clinical versus pharmacy environment. Eur J Clin Pharmacol. 2019;75(5):609-17.
Larmené-Beld KHM, Frijlink HW, Taxis K. A systematic review and meta-analysis of microbial contamination of parenteral medication prepared in a clinical versus pharmacy environment. Eur J Clin Pharmacol. 2019;75(5):609-17.
Plumridge RJ, Maher M. Justification of a pharmacy intravenous admixture service in an Australian hospital. Am J Hosp Pharm. 1993;50(3):463-6.
Shin H-J, Yang S, Lim Y. Antibiotic susceptibility of Staphylococcus aureus with different degrees of biofilm formation. J Anal Sci Technol. 2021;12(1):41.
Tabor A, Shalemariam Z, Alemu Y, Gorems K. Bacterial contamination of single and multiple-dose parenteral injection vials after opening and antibiotic susceptibility of isolates at Jimma Medical Center, Jimma, Southwest Ethiopia. Infect Prev Pract. 2023;5(3):100290.